Novocure Current Deferred Revenue vs Short Term Investments Analysis

NVCR Stock  USD 22.48  0.77  3.55%   
Novocure financial indicator trend analysis is infinitely more than just investigating Novocure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novocure is a good investment. Please check the relationship between Novocure Current Deferred Revenue and its Short Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Current Deferred Revenue vs Short Term Investments

Current Deferred Revenue vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novocure Current Deferred Revenue account and Short Term Investments. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Novocure's Current Deferred Revenue and Short Term Investments is 0.92. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Novocure, assuming nothing else is changed. The correlation between historical values of Novocure's Current Deferred Revenue and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Novocure are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Current Deferred Revenue i.e., Novocure's Current Deferred Revenue and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.92
Relationship DirectionPositive 
Relationship StrengthVery Strong

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Short Term Investments

Short Term Investments is an item under the current assets section of Novocure balance sheet. It contains any investments Novocure undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Novocure can easily liquidate in the marketplace.
Most indicators from Novocure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novocure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.At this time, Novocure's Selling General Administrative is relatively stable compared to the past year. As of 02/17/2025, Sales General And Administrative To Revenue is likely to grow to 0.67, while Tax Provision is likely to drop slightly above 9.1 M.
 2022 2023 2024 2025 (projected)
Interest Expense3.3M3.3M3.8M7.6M
Depreciation And Amortization10.6M11.0M12.6M7.8M

Novocure fundamental ratios Correlations

0.980.460.970.870.590.880.930.96-0.860.980.570.950.990.990.991.00.840.740.990.990.780.480.90.990.84
0.980.450.970.810.570.820.930.99-0.90.970.480.940.980.980.990.970.850.780.980.990.830.40.90.990.85
0.460.450.560.180.270.280.650.4-0.570.550.40.640.550.450.480.440.140.380.380.490.520.430.450.50.78
0.970.970.560.760.560.790.980.96-0.930.990.530.980.990.970.980.960.820.760.950.990.820.380.90.990.92
0.870.810.180.760.560.980.690.79-0.620.770.640.710.810.860.820.880.820.590.880.820.650.60.830.810.56
0.590.570.270.560.560.520.430.56-0.670.50.370.450.590.650.580.560.780.620.560.580.680.640.660.580.35
0.880.820.280.790.980.520.740.8-0.660.80.70.760.830.860.840.890.80.630.880.840.710.570.880.830.63
0.930.930.650.980.690.430.740.91-0.890.990.531.00.960.920.950.920.70.690.90.950.790.310.850.960.97
0.960.990.40.960.790.560.80.91-0.90.950.380.920.950.960.980.960.850.750.980.980.820.390.90.980.82
-0.86-0.9-0.57-0.93-0.62-0.67-0.66-0.89-0.9-0.89-0.36-0.9-0.89-0.88-0.89-0.84-0.82-0.74-0.85-0.9-0.93-0.36-0.91-0.9-0.86
0.980.970.550.990.770.50.80.990.95-0.890.540.990.990.960.980.970.780.720.950.980.790.350.880.990.93
0.570.480.40.530.640.370.70.530.38-0.360.540.540.590.570.530.570.460.520.470.540.410.430.560.540.49
0.950.940.640.980.710.450.761.00.92-0.90.990.540.970.930.960.940.720.710.920.960.790.330.860.970.96
0.990.980.550.990.810.590.830.960.95-0.890.990.590.970.990.990.980.820.770.960.990.80.460.90.990.89
0.990.980.450.970.860.650.860.920.96-0.880.960.570.930.990.990.990.880.780.980.990.80.490.90.990.82
0.990.990.480.980.820.580.840.950.98-0.890.980.530.960.990.990.990.840.770.981.00.80.430.91.00.86
1.00.970.440.960.880.560.890.920.96-0.840.970.570.940.980.990.990.830.710.990.990.750.470.880.990.83
0.840.850.140.820.820.780.80.70.85-0.820.780.460.720.820.880.840.830.80.840.840.80.460.890.840.55
0.740.780.380.760.590.620.630.690.75-0.740.720.520.710.770.780.770.710.80.70.770.760.480.780.770.59
0.990.980.380.950.880.560.880.90.98-0.850.950.470.920.960.980.980.990.840.70.980.770.450.890.980.8
0.990.990.490.990.820.580.840.950.98-0.90.980.540.960.990.991.00.990.840.770.980.810.440.91.00.87
0.780.830.520.820.650.680.710.790.82-0.930.790.410.790.80.80.80.750.80.760.770.810.430.950.810.76
0.480.40.430.380.60.640.570.310.39-0.360.350.430.330.460.490.430.470.460.480.450.440.430.480.420.26
0.90.90.450.90.830.660.880.850.9-0.910.880.560.860.90.90.90.880.890.780.890.90.950.480.90.78
0.990.990.50.990.810.580.830.960.98-0.90.990.540.970.990.991.00.990.840.770.981.00.810.420.90.88
0.840.850.780.920.560.350.630.970.82-0.860.930.490.960.890.820.860.830.550.590.80.870.760.260.780.88
Click cells to compare fundamentals

Novocure Account Relationship Matchups

Novocure fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets1.1B1.1B1.2B1.1B1.3B1.4B
Short Long Term Debt Total444.2M632.2M639.1M596.2M685.7M720.0M
Other Current Liab36.9M(17.8M)(18.0M)59.4M68.3M71.7M
Total Current Liabilities113.6M142.6M158.8M179.1M206.0M216.3M
Total Stockholder Equity476.5M410.5M441.2M362.5M416.9M279.7M
Other Liab11.7M17.6M11.2M7.4M8.5M8.8M
Net Tangible Assets217.8M476.5M410.5M441.2M507.3M267.8M
Property Plant And Equipment Net41.6M53.9M69.0M97.7M112.4M118.0M
Net Debt209.5M366.4M468.9M355.4M408.7M429.2M
Retained Earnings(631.1M)(685.9M)(778.5M)(985.5M)(887.0M)(931.3M)
Accounts Payable53.6M72.6M85.2M94.4M108.5M114.0M
Cash234.7M208.8M115.3M240.8M276.9M164.9M
Non Current Assets Total52.5M66.0M80.1M111.7M128.5M134.9M
Non Currrent Assets Other10.9M12.1M11.2M14.0M16.1M16.9M
Other Assets4.9M10.9M12.1M11.2M12.8M13.5M
Long Term Debt429.9M562.2M565.5M568.8M654.1M686.9M
Cash And Short Term Investments842.6M937.7M969.4M910.6M1.0B1.1B
Net Receivables96.7M110.6M112.2M77.1M88.7M60.9M
Common Stock Shares Outstanding108.9M103.4M104.7M106.4M122.3M96.1M
Short Term Investments607.9M728.9M854.1M669.8M770.3M808.8M
Liabilities And Stockholders Equity1.1B1.1B1.2B1.1B1.3B1.4B
Non Current Liabilities Total461.8M586.4M591.7M604.5M695.2M730.0M
Inventory27.4M24.4M29.4M38.2M43.9M23.2M
Other Current Assets32.7M807K6.7M8.5M9.8M6.6M
Other Stockholder Equity1.1B1.1B1.2B1.4B1.6B916.6M
Total Liab575.5M729.0M750.5M783.6M901.2M946.2M
Property Plant And Equipment Gross41.6M53.9M69.0M152.5M175.4M184.2M
Total Current Assets999.4M1.1B1.1B1.0B1.2B607.6M
Accumulated Other Comprehensive Income(3.8M)(3.2M)(2.4M)(5.5M)(4.9M)(4.7M)
Short Term Debt6.5M70.0M73.6M84.7M97.4M53.9M
Property Plant Equipment34.6M11.4M53.9M32.7M37.6M22.9M
Retained Earnings Total Equity(650.9M)(631.1M)(685.9M)(778.5M)(700.6M)(735.6M)
Current Deferred Revenue17.8M17.8M18.0M16.2M18.7M13.4M
Long Term Debt Total149.5M429.9M562.2M565.5M650.3M682.9M
Capital Surpluse871.4M1.1B1.1B1.2B1.4B1.0B
Non Current Liabilities Other31.9M166K148K18K20.7K19.7K
Net Invested Capital906.4M972.7M1.0B931.3M1.1B731.9M
Net Working Capital885.8M930.9M952.8M855.3M983.6M696.2M

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.